Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	530.68	331.15	279.05	230.04	265.88	7.02
Cash & Short-Term Investments	530.68	331.15	279.05	230.04	265.88	7.02
Cash Growth	84.33%	18.67%	21.30%	-13.48%	3687.41%	-69.82%
Accounts Receivable	0.39	0.14	-	18	-	-
Other Receivables	1.54	0.95	0.84	0.2	0.22	0.92
Receivables	1.92	1.09	0.84	18.2	0.22	0.92
Prepaid Expenses	2.38	1.64	2.28	1.38	0.97	0.15
Other Current Assets	17.06	13.42	3.6	1.82	0.66	0.84
Total Current Assets	552.05	347.29	285.77	251.44	267.73	8.93
Property, Plant & Equipment	24.19	19.47	17.57	2.4	1.6	1.91
Other Long-Term Assets	3.04	3.26	3.45	1.41	0.12	0.12
Total Assets	579.27	370.03	306.78	255.25	269.44	10.96
Accounts Payable	4.98	5.45	3.34	3.65	2.15	2.09
Accrued Expenses	21.82	17.25	12	7.03	4.21	1.71
Current Portion of Leases	1.86	1.01	0.46	0.86	0.42	0.38
Current Income Taxes Payable	-	-	-	0.11	0.19	0.04
Other Current Liabilities	0.35	0.67	0.75	0.2	0.22	0.27
Total Current Liabilities	29.01	24.37	16.55	11.85	7.18	4.49
Long-Term Debt	-	-	-	-	-	4.96
Long-Term Leases	17.43	13.44	12.81	0.23	0.48	0.9
Other Long-Term Liabilities	-	-	-	-	0.06	0.12
Total Liabilities	46.44	37.81	29.36	12.08	7.72	10.46
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,056	713.64	505.86	366.93	326.73	0.2
Retained Earnings	-522.75	-381.43	-228.43	-123.76	-65.01	-19.65
Total Common Equity	532.84	332.21	277.42	243.17	261.72	-19.45
Shareholders' Equity	532.84	332.21	277.42	243.17	261.72	0.5
Total Liabilities & Equity	579.27	370.03	306.78	255.25	269.44	10.96
Total Debt	19.29	14.44	13.27	1.09	0.9	6.23
Net Cash (Debt)	511.4	316.7	265.78	228.95	264.98	0.79
Net Cash Growth	86.93%	19.16%	16.09%	-13.60%	33483.90%	-96.07%
Net Cash Per Share	14.66	10.75	10.53	9.81	17.09	0.34
Filing Date Shares Outstanding	40.51	35.98	28.54	24	23.27	5.27
Total Common Shares Outstanding	39.26	31.84	27.54	23.97	23.19	5.27
Working Capital	523.04	322.92	269.22	239.59	260.54	4.44
Book Value Per Share	13.57	10.43	10.07	10.14	11.28	-3.69
Tangible Book Value	532.84	332.21	277.42	243.17	261.72	-19.45
Tangible Book Value Per Share	13.57	10.43	10.07	10.14	11.28	-3.69
Machinery	-	5.85	2.97	1.92	1.19	0.92
Leasehold Improvements	-	-	0.21	0.26	0.26	0.24

Source: S&P Capital IQ. Standard template. Financial Sources.